Velagliflozin proline hydrate

Overview

Velagliflozin proline hydrate is the clinical form of Velagliflozin ( HY-109018 ). Velagliflozin is an oral sodium-glucose cotransporter 2 ( SGLT2 ) inhibitor with antidiabetic activity. Velagliflozin reduces renal glucose reabsorption and stimulates glycosuria, which lowers blood sugar and insulin concentrations.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > SGLT

Product Information

• Catalog No.: HY-109018B
• CAS No.: 1661838-94-3
• Molecular Formula: C28H36N2O8
• Molecular Weight: 528.59
• Purity: 99.43%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 5 mg/mL (9.46 mM); Clear solution
• Availability: In-stock

Source

Original product source